Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Galafold (migalastat) Indicated for the Treatment of Fabry Disease

Drug Name

Galafold™ (migalastat)

Developer

Amicus Therapeutics

Therapy Class

Pharmacological chaperone therapy

Product Description

Alpha-galactosidase A (alpha-Gal A) pharmacological chaperone

Current Indication

Fabry Disease

Market Sector

Genetics

Development Status

Approved in the US
Expand

Go Top